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Introduction: Ketamine is a medication mainly used for starting and maintaining anesthesia. It induces a trance-
like state while providing pain relief, sedation and memory loss. Ketamine causes morphological changes in the 
neuronal cells of growing rodent. Centella asiatica is used for memory enhancement in the ayurvadic system of 
medicine. It has been shown to be useful in improving learning and memory. Centella asiatica leaf extract 
treatment enhances neuronal dendritic  arborization in hippocampus of growing rodent.Materials and Methods: 
Swiss albino mice were used for our experiment. Ketamine was administered subcutaneously and Centella-asiatica 
leaf extract was administered orally. Mice brain collected, grossed, processed and finally stained by Hematoxylin 
and Eosin (H&E) staining process for viewing cellular and tissue structure detail by pathologists. Results: Focal 
cellular damage was seen in CA2 and CA4 area of cornu ammonis (CA), expanded cytoplasmic eosinophilia saw 
in the pyramidal cell layers (PY) of CA2, expanded cytoplasmic eosinophilia found with obliteration of 
neurifibrilary components (NFE), typical pyramidal cell (NPY) in the CA4, ordinary engineering of dentate 
granule layers (DG) and hardly any cells were found with diminished size in regards to granule layer cells (GC) 
in the brain hippocampus of the high ketamine prompted mice. In the mouse brain hippocampus for high ketamine-
Centella asiatica summed up cell destruction found in the CA1 to CA4 of CA. Expanded cytoplasmic eosinophilia 
found in the pyramidal cell layers of CA2 than high dose ketamine group. The vast majority of the pyramidal cells 
were necrotic (PYN) with annihilation of neurofibrilary components (NFE) in the pyramidal cell layers of CA4.  
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Introduction 
Anesthetics activate memory-loss receptors in the brain, ensuring that patients don't remember traumatic events 
during surgery. The central nervous system has many parts. Hippocampus belongs to the limbic system and plays 
important role in the integration of information from short term memory to long term memory.[1] The dentate 
gyrus is part of a brain region known as the hippocampus (part of the hippocampal formation). The dentate gyrus 
is thought to contribute to the formation of new episodic memories,[2, 3] the spontaneous exploration of novel 
environments,[3] and other functions.[4] It is notable as being one of a select few brain structures currently known 
to have significant rates of adult neurogenesis in many species of mammals, from rodents to primates[5] (other 
sites include the subventricular zone of the striatum,[6] and cerebellum[7]. However, whether neurogenesis exists 
in the adult human dentate gyrus is currently a matter of debate.[8, 9]  
Ketamine is a medication mainly used for starting and maintaining anesthesia.[10] It induces a trance-like 
state while providing pain relief, sedation, and memory loss.[11] Other uses include for chronic pain, sedation in 
intensive care, and depression.[12-15] Heart function, breathing, and airway reflexes generally remain 
functional.[11] Effects typically begin within five minutes when given by injection, and last up to about 25 
minutes.[10] ketamine is used in medicine as an anesthetic;[16] however, due to the hallucinations it may cause, 
it is not typically used as a primary anesthetic, although it is the anesthetic of choice when reliable ventilation 
equipment is not available. 
Ketamine is frequently used in severely injured people and appears to be safe in this group.[17] A 2011 
clinical practice guideline supports the use of ketamine as a dissociative sedative in emergency medicine.[11] It is 
the drug of choice for people in traumatic shock who are at risk of hypotension.[18] Low blood pressure is harmful 
in people with severe head injury[19] and ketamine is least likely to cause low blood pressure, often even able to 
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prevent it.[20, 21]  
The effect of ketamine on the respiratory and circulatory systems is different from that of other anesthetics. 
When used at anesthetic doses, it will usually stimulate rather than depress the circulatory system.[22] It is 
sometimes possible to perform ketamine anesthesia without protective measures to the airways.[23] Ketamine is 
considered relatively safe because protective airway reflexes are preserved.[24] 
Ketamine is used as a bronchodilator in the treatment of severe asthma.[25] However, evidence of clinical 
benefit is limited.[25, 26]  
Antagonism of the NMDA receptor is thought to be responsible for the anesthetic, amnesic, dissociative, and 
hallucinogenic effects of ketamine.[27] The mechanism(s) of action for the antidepressant effects of ketamine at 
lower doses have yet to be fully elucidated.[28]  NMDA receptor antagonism results in analgesia by preventing 
central sensitization in dorsal horn neurons; in other words, ketamine's actions interfere with pain transmission in 
the spinal cord.[28] Inhibition of nitric oxide synthase lowers the production of nitric oxide– a gasotransmitter 
involved in pain perception, hence further contributing to analgesia.[29]  
Ketamine produces measurable changes in peripheral organ systems, including the cardiovascular, 
gastrointestinal, and respiratory systems:[29]  
 Cardiovascular: Ketamine stimulates the sympathetic nervous system, resulting in cardiovascular changes. 
 Gastrointestinal: Ketamine produces nausea and vomiting in 15 to 25% of individuals at anesthetic doses.[29]  
  Respiratory: Ketamine causes bronchodilation.[30] Several mechanisms have been hypothesized to explain 
this effect.[30]  
Drowsiness, dissociation, and psychosis-like effects (e.g., hallucinations, delirium) are reported in patients 
treated with ketamine starting at circulating concentrations of around 50 to 200 ng/mL (210–841 nM), while 
analgesia begins at levels of approximately 100 to 200 ng/mL (421–841 nM).[31, 32] The typical intravenous 
antidepressant dosage of ketamine used to treat depression is low and results in maximal plasma concentrations of 
70 to 200 ng/mL (294–841 nM).[33] Circulating concentrations of around 2,000 to 3,000 ng/mL (8,413–12,620 
nM) are employed during anesthesia, and patients may start to awaken once levels of ketamine have decreased to 
about 500 to 1,000 ng/mL (2,103–4,207 nM).[31, 32] There is wide variation in the peak concentrations of 
ketamine that have been reported in association with anesthesia in the literature, with values ranging from 2,211–
3,447 ng/mL (9,300–14,500 nM) to as high as 22,370 ng/mL (94,100 nM).[34, 35] Bioactive concentrations of 
ketamine are lower than total plasma levels due to plasma protein binding,[34] although plasma protein binding is 
relatively low with ketamine (approximately 12 to 47% protein-bound).[36] Concentrations of ketamine in the 
brain have been reported to be several-fold higher than in plasma.[35]  
An increasing number of in vitro and in vivo studies suggest that anesthesia and surgery could be risk factors 
for later cognitive impairment in the young and aged brain. General anesthesia has been shown to impair spatial 
memory in rats and this performance is dependent on hippocampal function and postnatal hippocampal 
neurogenesis. Anesthetic induced alteration of one or more stages of postnatal hippocampal neurogenesis may in 
part explain this cognitive impairment following anesthesia.[37] 
Centella asiatica is common herbaceous forest plant. It is used as vegetable and medicine. It is small size 
plant. Its leaves are green and flower is white and pinkish.  It is indigenous to the Indian subcontinent.[38, 39]  
Centella asiatica used to treat various diseases.[40] It is used in headaches, nausea cold fever and drowsiness. 
Another important use of it is for memory enhancement which used in the ayurvadic system of medicine. It has 
been shown to be useful in improving learning and memory.[40] In addition the plant is also used in mentally 
retarded children to improve general mental ability and in people suffering from cognitive disorders.[41] The fresh 
leaf juice (extract) of Centella asiatica has been claimed to improved learning and memory in different clinical 
studies.[42]  
Excessive stress causes neuronal degeneration. Stress like prolong and repeated use of anesthetic drug. 
Ketamine causes morphological changes in the neuronal cells of growing rodent.[43] On the other hand, Centella 
asiatica leaf extract treatment enhances neuronal dendritic  arborization in hippocampus of growing rodent.[43] 
But the cytoprotective property of Centella asiatica on the morphology of the hippocampal neuron has not been 
reported.[44] In this study numbers of mice were selected to receive high dose ketamine to induce anesthesia which 
is considered as stress, repeatedly for seven days in one group. In other group of mice received high dose ketamine 
with extract of Centella asiatica. Our aim was to observe types of morphological changes occurs in neurons of 
mice’s hippocampus after using high dose ketamine and high dose ketamine with high dose extract of Centella 
aisatica. 
 
MATERIALS AND METHODS 
Animal model 
15 Swiss albino mice were collected from animal resource department of ICDDR,B, Mohakhali Dhaka-1212. The 
mice were stored in metallic cage (5mice / cage) and given corn and water. Nearly identical weight mice were 
randomly divided in the three groups. Group A became control group, groups B changed into for high dose of 
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ketamine and group C was for high dose ketamine with Centella asiatca extract.  Mice are most typically used 
animal models for reading human disease for plenty proper reasons. Mice are biologically very just like human. 
 
Preparation of extract powder of Centella asiatica  
Green Centella asiatica sample was collected from Mohammadpur Town Hall Kacha Bazar Dhaka, Bangladesh 
and this was certified by National Herbarium, Mirpur-2, Dhaka, Bangladesh. The sample was cleaned and washed 
by water to remove dirty parts. Then the sample was dried under sunlight and converted to powder by mechanical 
blender and preserved in an air tight container at room temperature until extraction. 50gram dried powder was put 
into a glass beaker and added 250 ml methanol. Slow stirring was continued with a glass rod for one hour to mix 
up methanol and fine dried powder. The beaker was covered with aluminum foil and left for 48 hours. The mixture 
was filtered with thin cloth (white color) and the extract was taken to the water bath till dried extracts (crude drug) 
were obtained. The Temperature was always maintained at 40°C and finally the extract was collected by spatula 
in a marked glass vial. A total of 4gram dry powder extract was found and put into glass vial. The extract vial was 
kept in a refrigerator at 4°C temperature. 
 
Oral preparation of Centella asiatica powder extract and dosage form 
4gram extract powder was dissolved in 4ml 1% DMSO. Final concentration of Centella asiatica powder was 
1µg/μl. This solution was administered orally. 2μl solution per gram body weight was administered for each mouse 
those were dedicated for Centella asiatica. Same dosage form of Centella asiatica was used for the mice those 
were subjected for combined action of Centella asiatica and ketamine. 
 
Injectable preparation of Ketamine and dosage form 
Ketalar inection (ketamine 50mg/ml) of Popular Pharmaceutical Limited, Bangladesh was used as general 
anesthetics. Ketamine is a noncompetitive N-methyl-D-aspartate receptor antagonist that blocks glutamate. It has 
a direct action on the cortex and limbic system. It produces a cataleptic-like state wherein the patient is withdrawn 
from the surrounding environment. 2μl ketamine injection per gram body weight was administered subcutaneously 
for each mouse those were dedicated for ketamine. Like Centella asiatica same dosage form of ketamine was used 
for the mice those were subjected for combined action of Centella asiatica and ketamine. 
 
Mice brain collection 
At fast the Swiss albino mice were slaughtered with a sharp knife. Then removed the upper skin from the head and 
removed the skull by forceps and separated the brain. Separated brains then dipped into 10% buffer formalin 
fixative and sent to the laboratory for grossing. 
 
Brain grossing 
Control group: Brain sample was received in 10% buffer formalin fixative container with identification number. 
Brain weight was 10gm and dimension was 1.5x1.2x.0.6cm. Brain was sectioned into seven parts A1 to A7. At 
A3 hippocampus was identified. 
High dose ketamine: Brain sample was received in 10% buffer formalin fixative container with identification 
number. Brain weight was 11gm and dimension was 1.5x1.4x.0.6cm. Brain was sectioned into seven parts A1 to 
A7. At A3 hippocampus was identified. 
Ketamine with extract: Brain sample received in 10% buffer formalin fixative container with identification 
number. Brain weight was 9gm and dimension was 1.3x1.0x.0.6cm. Brain was sectioned into seven parts A1 to 
A7. At A3 hippocampus was identified. 
 
Brain tissue processing 
Brain tissue processing was accomplished by following a well known procedure written by Geoffrey Rolls for 
Leica Biosystems, Wetzlar, Germany.[55][56][57][58] (Source: https://www.leicabiosystems.com/knowledge-
pathway/an-introduction-to-specimen-processing/) 
  
Brain tissue staining 
Hematoxylin and Eosin (H&E) staining process was used for viewing cellular and tissue structure detail by 
pathologists. Brain tissue staining was accomplished by following a well known protocol written by Cindy 




In our study we set three groups of Swiss albino mice of similar weight. One group was considered as control, one 
group was considered for high dose ketamine subcutaneous administration and last group was selected for high 
Advances in Life Science and Technology                                                                                                 www.iiste.org 




dose ketamine subcutaneous administration with high dose Centella asiatica oral administration. 
We found dimension change in the brain of the three mice groups. High dose ketamine with high dose 
Centella asiatica administered mice group found with reduced dimension, 1.3x1.0x.0.6cm, then followed control 
group, 1.5x1.4x0.6cm, and high dose ketamine group, 1.5x1.2x0.6cm. 
Starting at the dentate gyrus and working inward along the S-curve of the hippocampus means traversing a 
series of narrow zones. The first of these, the dentate gyrus (DG), is actually a separate structure, a tightly packed 
layer of small granule cells wrapped around the end of the hippocampus proper, forming a pointed wedge in some 
cross-sections, a semicircle in others. Next come a series of Cornu Ammonis (CA) areas: first CA4 (which 
underlies the dentate gyrus), then CA3, then a very small zone called CA2, then CA1. The CA areas are all filled 
with densely packed Pyramidal cells similar to those found in the neocortex. After CA1 comes an area called the 
subiculum. After this comes a pair of ill-defined areas called the presubiculum and parasubiculum, then a transition 
to the cortex proper (mostly the entorhinal area of the cortex). Most anatomists use the term "hippocampus proper" 
to refer to the four CA fields, and hippocampal formation to refer to the hippocampus proper plus dentate gyrus 
and subiculum.[59] 
 
Figure-1: Basic circuit of the hippocampus, shown using a modified drawing by Ramon y Cajal. DG: dentate 
gyrus. Sub: subiculum. EC: entorhinal cortex 
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Figure 2-Effect of high dose ketamine and high dose ketamine plus high dose Centella asiatica on mice brain 
Figure-2 showed the morphophological effect of high dose ketamine and high dose ketamine with Centella 
asiatica on dentate gyrus.  
We observed focal cellular reduction in CA2 and CA4 region of cornu ammonis (CA), increased cytoplasmic 
eosinophilia observed in the pyramidal cell layers (PY) of CA2, increased cytoplasmic eosinophilia found with 
destruction of neurifibrilary elements (NFE), normal pyramidal cell (NPY) in the  CA4, normal architecture of 
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dentate granule layers (DG) and few cells were found with reduced size regarding granule layer cells (GC) in the 
brain of the high ketamine induced mice. 
For high ketamine-Centella asiatica mice group generalized cellular reduction found in the CA1 to CA4 
region of cornu ammonius. Increased cytoplasmic eosinophilia found in the pyramidal cell layers of CA2 than 
high dose ketamine. Most of the pyramidal cells were necrotic (PYN) with destruction of neurofibrilary elements 
(NFE) in the pyramidal cell layers of CA4.  
 
Discussion 
As manufactured medications can prompt lung and kidney lethality, numerous clinicians and researchers have 
looked enthusiastically for different choices to treat their patients. Home grown plants which are normally wealthy 
in remedial worth, more eco-accommodating and have lesser symptoms have been consequently read for usage in 
therapeutic applications. This has brought Centella asiatica, which is known to have memory and subjective 
improvement, into logical examinations for nerve recovery and neurological capacities before helpful use. 
Research on the neuroregenerative limit of Centella asiatica on the focal sensory system has been broadly 
directed, concentrating on synapses. Soumyanath et al. [45] uncovered the capacity of asiatic acid (AA) to advance 
the lengthening of neurites utilizing an in vitro test model. They additionally saw that this activity could be co-
animated with the other dynamic mixes found in the herb that have synergistic impacts with AA. In parallel with 
this, Rao et al. [42] announced that crisp Centella asiatica leaf separate fundamentally expands the dendritic 
arborisation of hippocampal CA3 neurons in vivo. In perspective on Centella asiatica as a nerve tonic [46], it is 
accepted to effectsly affect the fringe sensory system as well. Nonetheless, further examinations are expected to 
bring it into proof, as the writing on such sensory system benefits is excessively constrained to date. 
Since variation of extract constituents can lead to various complications, scientists from Thailand have 
recently established a standardized extract of Centella asiatica known as ECa 233 [47]. The extract was clearly 
demonstrated to have stimulatory effects on the elongation of neuroblastoma cell neurites at a maximum dose of 
100 μg/mL [48]. In spite of dendritic arborisation, this particular herb also exhibits neuroprotective properties. 
Zhang and his colleagues [49] have recently disclosed that AA ameliorates the action of C2-ceramide in inducing 
neuronal cell death in a concentration-dependent manner. 
Despite the fact that the fundamental mechanisms whereby the herb applies its belongings are ineffectively 
comprehended, the previously mentioned properties synchronize with the dominance of this herb to phosphorylate 
a few flagging pathways to intercede its capacities. In fact, the components associated with neurite advancement 
are very mind boggling, yet the MEK/ERK and PI3/Akt signaling pathways have increased noteworthy 
consideration [50]. A past report explained that AA in Centella asiatica evokes its neuroregenerative impact by 
means of the MAP kinase pathway [45]. In concurrence with this, Wanakhachornkrai et al. [48] additionally 
uncovered that ECa 233 is MEK/ERK-and PI3K/AKT-subordinate in advancing the extension of neurites. 
Other than that, Omar et al. [51] as of late uncovered the guideline of the caspase-9 pathway by Centella 
asiatica in adjusting neuron cell endurance against apoptosis. In this investigation, l-buthionine-(S,R)- sulfoximine 
(BSO)- incited human neuron cell demise was treated with ethanolic concentrate of Centella asiatica in the scope 
of 5–500 μg/mL. They found that, at low concentrations, this extract can ensure neuron cells against oxidative 
pressure. This may point to the limit of this herb in restraining the caspase-9 pathway by blocking the creation of 
proapoptotic proteins, advancing antiapoptotic proteins and copying the last mentioned [43, 44]. Despite the fact 
that this mechanism is evidently centered around neuroprotective impacts against apoptosis, such a system could 
be a subset in the recovery and upgrade of nerve cell wounds. All the previously mentioned mechanisms cover 
each other in keeping up nerve cell development.  
In the above discussion we found beneficiary role of Centella asiatica regarding neuroprotection, 
neuroregeneration, dendritic arborisation, antiapoptosis. We did not find any data regarding co-administration of 
Centella asiatica with ketamine or any other anesthetics. In our study we found no positive role of Centella asiatica 
with ketamine. In the ketamine induced brain we found increased cytoplasmic eosinophilia in the pyramidal cell 
layers of CA2. Most of the pyramidal cells were found necrotic (PYN) with destruction of neurofibrilary elements 
(NFE) in the pyramidal cell layers of CA4.  
 
Conclusion 
In the combined action of ketamine and Centella asiatica, Centella asiatica exerted no physiologically positive 
impact in the mice brain hippocampus. Hippocampus found with increased cytoplasmic eosinophilia, necrosis with 
decreased neurofibrilary elements (NFE) .   
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